Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Advanced or Metastatic Urinary Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00714948
What this trial is testing

Gemcitabine and Split-dose Cisplatin (GC) Plus Sorafenib in Chemotherapy-naïve Patients With Locally Advanced or Metastatic Urothelial Carcinoma

Who this might be right for
Bladder CancerURINARY BLADDER
Memorial Sloan Kettering Cancer Center 2
Testing effectiveness (Phase 2)Ended earlyNCT03324282
What this trial is testing

First-line Gemcitabine/Cisplatin +/- Avelumab in Locally Advanced or Metastatic Bladder Carcinoma

Who this might be right for
Bladder Carcinoma
University Hospital, Bordeaux 65
Large-scale testing (Phase 3)Study completedNCT02302807
What this trial is testing

Atezolizumab Compared With Chemotherapy in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer [IMvigor211]

Who this might be right for
Bladder Cancer
Hoffmann-La Roche 931
Testing effectiveness (Phase 2)Active Not RecruitingNCT05327530
What this trial is testing

The Safety and Efficacy of Various Combinations of Avelumab as Therapy in Locally Advanced or Metastatic Urothelial Carcinoma (JAVELIN Bladder Medley)

Who this might be right for
Locally Advanced or Metastatic Urothelial Carcinoma
EMD Serono Research & Development Institute, Inc. 256
Testing effectiveness (Phase 2)Study completedNCT00627432
What this trial is testing

Gemcitabine With Or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Bladder Cancer

Who this might be right for
Bladder Cancer
Institut du Cancer de Montpellier - Val d'Aurelle 44
Testing effectiveness (Phase 2)Study completedNCT00003175
What this trial is testing

Fluorouracil in Treating Patients With Recurrent or Metastatic Bladder Cancer

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer
Medical Research Council 45